In an insulin-resistant milieu, insulin may competitively inhibit IDE, which impedes the degradation of Aβ proteins, increases their neurotoxicity, and contributes to the onset of AD (Scherer et al., 2021; Ochiai et al., 2021). Here, INS is linked to Alzheimer disease.